| Dr William M Chop Jr, MD | |
|
1600 Providence Dr, Waco, TX 76707-2261 | |
| (254) 313-4200 | |
| (254) 313-4531 |
| Full Name | Dr William M Chop Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1600 Providence Dr, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639156425 | NPI | - | NPPES |
| 132141601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | J0460 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heart Of Texas Community Health Center, Inc. | 1153370242 | 95 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease.
Rep. Kevin Brady, R-Texas, announced he will seek the chairmanship of this powerful House panel. Rep. Paul Ryan, R-Wis., was expected to have a smooth path to that position.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the completion of enrollment in its ongoing pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis (PDP).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology.
› Verified 4 days ago
| Entity Name | Mclennan County Medical Education And Research Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689651440 PECOS PAC ID: 0042205155 Enrollment ID: O20040419000208 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease.
Rep. Kevin Brady, R-Texas, announced he will seek the chairmanship of this powerful House panel. Rep. Paul Ryan, R-Wis., was expected to have a smooth path to that position.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the completion of enrollment in its ongoing pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis (PDP).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology.
› Verified 4 days ago
| Entity Name | Heart Of Texas Community Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568191492 PECOS PAC ID: 1153370242 Enrollment ID: O20050114000813 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease.
Rep. Kevin Brady, R-Texas, announced he will seek the chairmanship of this powerful House panel. Rep. Paul Ryan, R-Wis., was expected to have a smooth path to that position.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the completion of enrollment in its ongoing pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis (PDP).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William M Chop Jr, MD 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 | Dr William M Chop Jr, MD 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease.
Rep. Kevin Brady, R-Texas, announced he will seek the chairmanship of this powerful House panel. Rep. Paul Ryan, R-Wis., was expected to have a smooth path to that position.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the completion of enrollment in its ongoing pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis (PDP).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology.
› Verified 4 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Jacob Lutgen, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |